Today, most leading doctors in India are themselves not promoting the Ministry of Health guidelines that includes the use of hydroxychloroquine, ivermectin and inhaled budesonide.
If you were going to try and design a drug, for the disease that we call COVID-19, you would want something with heavy anti-viral properties, as well as anti-inflammatory properties.
When you think about that, it’s hard to come up with a better drug for Covid than ivermectin. It literally does both of those things simultaneously, and it’s one of the safest drugs known to man.
The International Ivermectin for Covid Conference: Dr. David Chesler shares his experience of using ivermectin to prevent and treat covid-19 infection amongst care home residents.
Medical experts from around the world joined together to present the very latest real world research on repurposing ivermectin that has the ability to transform global efforts to fight the pandemic. Mr. Andrew Bryant provides an overview of ongoing trials and what they may add to the evidence base.
Dr. Tess Lawrie presents the latest systematic review evidence from RCTs and a selection of resource, equity, acceptability and feasibility considerations related to ivermectin use for COVID-19
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. In this talk, speaker Dr. Mobeen Syed provides an overview of ivermectin and how it works against covid-19.
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 235 studies to date is estimated to be 1 in 6 quadrillion (p = 0.00000000000000018).
Early treatment is most successful, with 100% of 29 studies reporting a positive effect (13 statistically significant in isolation) and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.35 [0.25-0.50].
92% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.0017.
It is high time to open our eyes, to hold our governments to account, and to fundamentally reform a system that has been misled by the interests of the all-powerful pharmaceutical industry. ”
In an interview with Alan Jones, Craig Kelly MP discusses the vaccine rollout mishaps and yet again, rightfully points out the myriad of medical specialists around the world who support the use of ivermectin for the prophylaxis and treatment of their Covid-19 patients with the backup of extensive positive data.
Source: The New American Author: Annalisa Pesek Calls are increasing for investigations into Dr. Anthony Fauci’s intentional suppression of inexpensive and easily accessible, life-saving treatments for COVID-19.
The World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19. And those who want to end this pandemic now, for all countries rich and poor, should welcome that move.
We discussed the Surgisphere debacle and other stories of “engineered research” during the pandemic, most of which I am currently preparing articles about.
The purpose of this study was to assess the effect of oral Ivermectin treatment, which has been associated with iota-carrageenan in repeated doses through the nasal and oral topical route, on the appearance and eventual progression of COVID-19 disease in a healthy population that are exposed to it and have a higher risk of contagion of SARS-COV-2 for being health personnel from
Ivermectin had a significant effect (p=0.003) in achieving medical release. The treatment with ivermectin could significantly prevent the evolution to serious stages since the experimental group did not present any patient with referral to critical hospitalization.
Source: Rounding the Earth Author: Mathew Crawford The story of why hydroxychloroquine (HCQ) has not been used broadly in most Western nations (primarily in the
The Hydroxychloroquine Hypothesis: That there is some appropriate dosage of hydroxychloroquine, alone or in some combination with other medication, that successfully prevents some COVID-19 cases (PrEP/PEP) or treats some COVID-19 sufferers (Early/Late/Critical).
Remaining entirely unblemished after a year of trials and observations, the current evidence in favor of the Primary HCQ Hypothesis fully validates the HCQ Hypothesis. The logic is so simple that it almost feels like your livelihood would have to be on the line to deny it.
This is now one of the most well-studied treatments in the history of medicine, and the evidence is overwhelming. The chance that these results could occur at random is approximately 1 in 208 quadrillion. That is, p = 0.000000000000048. Having read a few thousand research papers, I have never before seen a p-value this low in the testing of medicine.
Early treatment intervention with hydoxychloroquine & Ivermectin appears to have played a major role in control in India, precipitating local herd immunity.
Ivermectin is an effective treatment for COVID-19. The probability that an ineffective treatment generated results as positive as the 42 studies to date is estimated to be 1 in 4 trillion (p = 0.00000000000023).
Source: Communities Digital News Author: Rick Johnson LOS ANGELES, CA: As the COVID-19 pandemic explodes in the New York region and across California, the Malaria
The UK has had the ignominious triumph of having one of the world’s highest death rates. Some see the solution in continuing lockdowns, more testing and ultimately the vaccine. We argue that the solution lies in medical treatments, such as hydroxychloroquine or ivermectin rather than in vaccination. But hydroxychloroquine was ruled out as a potential treatment for covid19 quite early on. This is despite the fact that, when used correctly, it is a highly efficacious treatment. Had it been readily available as a prophylactic or early stage treatment we would need neither lockdowns nor vaccinations and dramatically fewer people would have died. However this didn’t happen. Here we intend to explore why.
We conclude that two-dose ivermectin prophylaxis at a dose of 300 μg/kg body weight with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among HCWs in the following one month. Chemoprophylaxis has relevance in the containment of pandemic. This is an intervention worth replicating at other centers until a vaccine is widely available.
Early Covid treatment advocates Craig Kelly MP (Federal Member For Hughes, Australia) and Dr Vladimir Zelenko discuss the background behind the development of the ‘Zelenko Protocol’ – a combination of hydroxychloroquine, azithromycin and zinc – for the early treatment of Covid-19.
Source: ABC Radio In an interview with the ABC’s ‘On Drive with Paul Turton’, Professor Clancy explains his conclusions from the many studies available. Robert
Source: 6PR Mornings Australian medical bioscientist and clinical immunologist Robert Clancy, an expert in the relationship between infection and the airways, declares “the data is
We tested the hypothesis that aerosolized HCQ sulfate (aHCQ) tolerably, safely, and rapidly achieves high respiratory tissue concentrations, while minimizing systemic toxicity.
Source: ivmmeta.com Figure 1. A. Random effects meta-analysis excluding late treatment. Simplified dosages are shown for comparison, these are the total dose in the first two days
Source: Research Gate SHOUMAN WM1, HEGAZY AA2, NAFAE RM3, RAGAB ME4, SAMRA SR5, ANAS D6, AL-MAHROUKY TH7, SILEEM AE8DO – 10.7860/JCDR/2020/46795.0000 INTRODUCTION An outbreak of
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.
Source: Quadrant Online Author: Robert Clancy Robert Clancy: The author is Emeritus Professor of Pathology at the University of Newcastle Medical School. He is a
HCQ is effective for COVID-19. The chance that an ineffective treatment generated results as positive as the 187 studies to date is 1 in 5 quadrillion (p = 0.00000000000000019).
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version 28, December 4, 2020) • HCQ is effective for COVID-19.
Source: MedRxIV David M. Wiseman, Pierre Kory, Samir A Saidi, Dan Mazzucco doi: https://doi.org/10.1101/2020.11.29.20235218 Abstract BACKGROUND A recent trial (NCT04308668) found that post-exposure prophylaxis with hydroxychloroquine (HCQ) was associated with a reduced incidence
Source: America’s Frontline Doctors THIS IS NOT MEDICAL ADVICE. Every situation is unique, and every person must check with his or her own physician, especially
Results obtained in the prophylaxis of Q fever indicate that chloroquine/hydroxychloroquine can be successfully used in the clinical management of infections other than malaria.
Source: Science Direct Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P,Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers, New Microbesand
We should learn from the countries that have been using the drug. The dramatic fall in death rates that occurred after hydroxychloroquine treatment was initiated in countries like India, Brazil and Ecuador can no longer be ignored. To do so, and to continue to interfere with a doctor’s right to prescribe HCQ to their patients, is reckless and immoral.
Source: Journal of Marine Medical Society Date of Submission 23-Aug-2020 Date of Decision 18-Sep-2020 Date of Acceptance 29-Sep-2020 Date of Web Publication 06-Nov-2020 Correspondence Address:Vivek
Source: Science Direct Dr. Deba PrasadDhibarMD(Assistant Professor)aDr. NavneetAroraMD(Senior Resident)aDr. ArpitKakkarDNB(Senior Resident)aDr. NeerajSinglaMD(Assistant Professor)bDr. RitinMohindraMD(Assistant Professor)bDr. VikasSuriMD(Additional Professor)bDr. AshishBhallaMD(Professor)bDr. NavneetSharmaMD(Professor)bDr. Mini PSinghMD(Professor)cDr. AjayPrakashPhd(Assistant Professor)dDr. LakshmiPVMMD(Professor)eDr. BikashMedhiMD(Professor)d
Source: HCQmeta.com • HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 132 studies to date is
